Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Home >
China Vaccine Industry Report, 2008-2009
Management Report
Published: August 2009
Pages: 77
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 906.25 Buy Now!
Research from: ResearchInChina
Sector: Prescription Medicines
In the past decade, the Chinese vaccine market tripled in scale. China has already become the world’s largest vaccine producer and now has 28 vaccine companies, ranking NO.1 around the globe. It can produce one billion person-portions annually, besides, varieties and quantity it also ranks the top in the world.
Output of common vaccine reaches 500 million person-portions such as HBV vaccine, measles vaccine, etc. Fully planned immunization has been realized.
Compared to developed countries, expenses of China on vaccine and diseases treatment are relatively low; therefore, China will attach great importance to vaccine industry development and takes it as the key of healthcare and bio-technology industry. The Development Strategy of China Bio-technology Industry has rendered the development of secure new types of vaccines as priority; in the meantime, the Chinese government has employed preferential taxation policy to this industry. In consequence, the vaccine industry will become a high-tech sector with great potential in China’s bio-technology field. It is forecasted that China’s vaccine market scale will approximate RMB8 billion in 2020, with an annual growth rate of 15%, far above world’s level 10%.
Based on authoritative statistics, this report gives an in-depth analysis on China vaccine industry development, vaccine market, vaccine import & export, key vaccine producers, and also forecasts the development trend of China's vaccine industry in 2009. Vaccines involved in this report are Flu Vaccine, HBV Vaccine, Cerebrospinal Meningitis Vaccine, HIV vaccine, A/HINI vaccine as well as anima vaccines.
Compared to developed countries, expenses of China on vaccine and diseases treatment are relatively low; therefore, China will attach great importance to vaccine industry development and takes it as the key of healthcare and bio-technology industry. The Development Strategy of China Bio-technology Industry has rendered the development of secure new types of vaccines as priority; in the meantime, the Chinese government has employed preferential taxation policy to this industry. In consequence, the vaccine industry will become a high-tech sector with great potential in China’s bio-technology field. It is forecasted that China’s vaccine market scale will approximate RMB8 billion in 2020, with an annual growth rate of 15%, far above world’s level 10%.
Based on authoritative statistics, this report gives an in-depth analysis on China vaccine industry development, vaccine market, vaccine import & export, key vaccine producers, and also forecasts the development trend of China's vaccine industry in 2009. Vaccines involved in this report are Flu Vaccine, HBV Vaccine, Cerebrospinal Meningitis Vaccine, HIV vaccine, A/HINI vaccine as well as anima vaccines.